PAVmed Inc. - Series Z
PAVMZ NASDAQ

PAVMZ
PAVmed Inc. - Series Z NASDAQ
Trade now
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Trade now

PAVMZ Stock Warrant Chart

Profile

Sector: Health Technology
Industry: Medical Specialties
PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: GI Health, Minimally Invasive Interventions, Infusion Therapy, and Emerging Innovations. The GI health division comprises of EsoGuard esophageal DNA laboratory developed test, EsoCheck Esophageal Cell Collection Device, and EsoCure Esophageal Ablation Device with Caldus technology. The minimally invasive interventions division offers CarpX minimally invasive surgical device for carpal tunnel syndrome. The infusion therapy division includes PortIO implantable intraosseous vascular accedd device and NextFlo highly accurate disposable intravenous infusion platform technology. The emerging innovations divisions consists of non-invasive laser-based glucose monitoring, single-use ventilators, resorbable pediatric ear tubes and mechanical circulatory cannulas. The company was founded on June 26, 2014 and is headquartered in New York, NY.

News